MarginsXMarginsX
Home › Markets › BHIC

BioScience Health Innovations, Inc. (BHIC)

BHIC is quoted over the counter, not listed on an exchange. BioScience Health Innovations, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 13, 2026
$5.00
-0.6% on the day
1-year return
+25.0%
Market cap
$60.1M
Micro cap. From the Nov 13, 2026 close × 12M shares (10-Q cover page, Nov 13, 2026)
P/E and P/S
Net loss over the period · 13.4×
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerBHIC, quoted over the counter
SEC CIK0001784440
OTC Markets tierOTCID (price source, 2026-11-13)
SEC industry codeServices-Computer Processing & Data Preparation
Business addressBluffdale, UT
Incorporated inNV

Warning signs

Cash runway
5.6 months
$712K cash at June 30, 2026
Share count, 1 year
+9.5%
2025-10-24 to 2026-11-13 · +17.9% over 3 years
Going-concern doubt
No
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-13
Cash and burn$712K cash; operating cash flow -$384K a quarter.Report 2026-06-30
Shares outstanding12,027,217 (2026-11-13); 10,979,055 a year earlier; 40,792,600 three years earlier. 3y figure adjusted for split (1-for-4 overall).Cover page 2026-11-13
Reverse splits, 3 years1; latest 1-for-4 on 2025-09-26Source 2025-09-26
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorMAC ACCOUNTING GROUP & CPAS, LLP, Midvale, Utah, United StatesPCAOB Form AP 2026-04-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$1.0M-$186K-$542K$712K$260K$4.5M10-Q 2026-08-07
Q1 2026
2026-03-31
$751K-$230K-$552K$1.1M$460K$5.2M10-Q 2026-05-11
Q4 2025
2025-12-31
$1.6M-$234K-$101K$662K$0$5.7M10-K 2026-03-30
Q3 2025
2025-09-30
$1.1M-$9K-$340K$1.1MNo debt tags$4.7M10-Q 2025-10-27
Q2 2025
2025-06-30
$1.8M$458K$285K$1.3MNo debt tags$4.2M10-Q 2026-08-07
Q1 2025
2025-03-31
$1.2M$427K$328K$1.0MNo debt tags$2.8M10-Q 2026-05-11
Q4 2024
2024-12-31
$610K$10K-$50K$663KNo debt tags$1.8M10-K 2026-03-30
Q3 2024
2024-09-30
$573K$56K$52K$333KNo debt tags$1.5M10-Q 2025-10-27

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document1-A2025-11-25
Latest annual report10-K2026-03-30
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-04-02

Source: SEC EDGAR submissions feed, 54 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier